ahlam1399
09-11-2015, 06:54 PM
Amgen seeks FDA approval for monthly dosing option for Repatha
Sept 11 (Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2.img (http://da.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/ach.img (http://adchoice.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/ach.htm)http://pi.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2t.imghttp://pi2.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49c4c6c9/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=-EfBOjk3jeY:McpQ9yti5HE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=-EfBOjk3jeY:McpQ9yti5HE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/-EfBOjk3jeY
Sept 11 (Reuters) - Amgen Inc said it had asked the U.S. Food and Drug Administration to approve a monthly single-dosing option for its recently approved cholesterol drug, Repatha.
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2.img (http://da.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/ach.img (http://adchoice.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/ach.htm)http://pi.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2t.imghttp://pi2.feedsportal.com/r/238385660959/u/49/f/654213/c/35217/s/49c4c6c9/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/49c4c6c9/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=-EfBOjk3jeY:McpQ9yti5HE:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=-EfBOjk3jeY:McpQ9yti5HE:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=-EfBOjk3jeY:McpQ9yti5HE:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/-EfBOjk3jeY